Our Partners
Coast to Coast
Evict Radon
Evict Radon
The Evict Radon team is based at the University of Calgary and is composed of Canadian investigators and staff with a strong track record of innovation, science engagement, public outreach, and high impact publications in areas of complementary expertise including radon exposure, molecular epidemiology and radiation biology. We are ideally positioned to predict and prevent radon-associated lung cancer in Canada.
Carex Canada
CAREX Canada is a national surveillance project that estimates the number of Canadians exposed to substances associated with cancer in workplace and community environments.
These estimates provide significant support for targeting exposure reduction strategies and cancer prevention programs.
Health and Environments Research Centre Laboratory
Researchers at the Health and Environments Research Centre Laboratory collaborate with other investigators and industrial partners locally and globally, to examine the sources, fate, transport and metabolism of aerosols of health significance in human environments and ecosystems.
Integrated Microbiome Resource (IMR)
The Integrated Microbiome Resource (IMR) was established in 2014 through support by the Strategic Research Initiatives Fund (SRIF) from the Office of the Vice-President Research, Dalhousie University. Directed by Dr. Morgan Langille (Dept. of Pharmacology, Dalhousie University), the IMR seeks to strengthen and centralize resources microbiome resources to allow: 1) Integration of metagenomics/microbiomics data production and analysis within the Dalhousie research community; 2) Develop/disseminate "best practices" for data/result compatibility; 3) Train students and post-docs comprehensively in laboratory and computational techniques; 3) Link/integrate existing basic science and translational research projects; 4) Effect new projects/collaborations attractive to external research funders; 5) Develop community outreach encouraging metagenomics/microbiomics; 6) Establish multidisciplinary consultative microbiomic resources; 7) Facilitate public/private collaborative microbiomics in Atlantic Canada. The IMR, through partnership with CE2C, will facilitate new research into the effects of environmental exposures on the human gut microbiome that in turn may contribute to the development of chronic diseases including cancer.
The Centre for Genomics Enhanced Medicine (CGEM)
The Centre for Genomics Enhanced Medicine (CGEM) at Dalhousie University was established with the vision of improving health through translational genomics. CGEM's mission is to deliver medical genomic research that translates into life-changing tests and treatments for people affected by acquired and inherited diseases. Through ongoing resource and facility partnerships, CGEM has the infrastructure, knowhow, and network of dedicated members to ensure its research discoveries are translated into new patient-oriented treatments. In this regard, CGEM has partnered with CE2C to help facilitate discussion and research collaborations for evidenced-based research in the area of gene-environment interactions in human disease.
Beatrice Hunter Cancer Research Institute
The Beatrice Hunter Cancer Research Institute was created in 2009 to foster a more collaborative, productive and capacity-building cancer research effort in Atlantic Canada.
Based in Halifax, Nova Scotia, the Beatrice Hunter Cancer Research Institute is a virtual institute that brings together a diverse community of cancer researchers in pursuit of a common goal: to save lives and ease the burden of cancer on individuals, families and society.
The Beatrice Hunter Cancer Research Institute is named in grateful memory of the late Mrs. Beatrice Hunter, who in 1999, bequeathed $12.5 million to the Dalhousie Medical Research Foundation for cancer research, in memory of her parents, Dr. Owen and Mrs. Pearle Cameron. The bequest was placed in the Cameron Endowment Fund, which generates approximately $500,000 per year for cancer research at Dalhousie Medical School.
Atlantic PATH
The Atlantic Partnership for Tomorrow’s Health Study, or Atlantic PATH as we usually call ourselves, is part of the Canadian Partnership for Tomorrow Project (CPTP), the largest study of its kind ever undertaken in Canada. This national study is investigating how genetics, the environment, lifestyle, and behavior contribute to the development of chronic diseases. CPTP is following the health of 300,000 people for 30 years in British Columbia, Alberta, Ontario, Quebec, and in Atlantic Canada.
This work is particularly important for Atlantic Canada, which has the highest rates of cancer in the country. Every year, more than 13,400 Atlantic Canadians are diagnosed with cancer and 6,300 die as a result. The disease truly does touch everyone living in this region, either personally or through family and friends.
Alberta's Tomorrow Project
As Alberta’s largest health research study, ATP aims to reveal what causes and what may prevent cancer and chronic diseases. Following the health of 55,000 men and women for the next 50 years, this long-term cohort study provides exceptional depth and breadth of detailed information to researchers around the world. Thanks to hundreds of thousands of pieces of data and biological samples, scientists will be able to explore how lifestyle, genetics and environment influence the health of generations to come.
BC Generations Project
The BC Generations Project is British Columbia’s largest-ever health study. The Project follows a cohort of nearly 30,000 BC participants who volunteer their health information and biological samples to help researchers learn more about how environment, lifestyle and genes contribute to cancer and other chronic diseases.
Manitoba Tomorrow Project
The Manitoba Tomorrow Project (MTP) is the newest emerging cohort of the Canadian Partnership for Tomorrow Project (CPTP). MTP is a long-term population health initiative (translational research program) seeking to involve the participation of at least 10,000 Manitoba residents. The MTP aims to serve as a research resource for cancer and chronic disease prevention for the decades to come.
Ontario Health Study
The Ontario Health Study is an ongoing research study investigating risk factors that cause diseases like cancer, diabetes, heart disease, asthma and Alzheimer’s. Between 2009 and 2017, the OHS recruited over 225,000 Ontario residents over the age of 18 to complete health-related questionnaires online, with follow-up questionnaires administered over time to follow their health as they age. Researchers will use this health information to study how our lifestyle, environment and family history affect our health over time and to develop strategies for the prevention, early detection and treatment of diseases.
CARTaGENE
CARTaGENE is a public research platform of the CHU Sainte-Justine created to accelerate health research. CARTaGENE consists of both biological samples and health data from 43,000 Québec residents aged between 40 to 69 years. Originally founded by Dr. Claude Laberge and Prof. Bartha Maria Knoppers, CARTaGENE is now under the scientific direction of Dr. Ekaterini Kritikou, Dr. Sébastien Jacquemont, and Dr. Philippe Broët, researchers at the CHU Sainte-Justine. CARTaGENE will enable to improve prevention, diagnosis and treatment of chronic diseases such as heart disease, diabetes and cancer. CARTaGENE will therefore contribute to the improvement of the Quebec healthcare system.